Weight loss in older persons: new therapeutic approaches

Curr Pharm Des. 2007;13(35):3637-47. doi: 10.2174/138161207782794149.

Abstract

There is now a large body of evidence that weight loss in older persons not only increases mortality, but also increases the incidence of hip fracture, functional deterioration and institutionalization. Weight loss is a central component of frailty. There is evidence that it is not only muscle, but also fat loss that leads to these deleterious effects. The reasons why fat loss can be harmful in older persons are reviewed. There are four major causes of weight loss in older persons viz. anorexia, sarcopenia, cachexia and dehydration. This review concentrates on the major causes of anorexia and sarcopenia. In particular, the emergence of new medications such as selective androgen receptor molecules, antimyostatin analogues, megestrol acetate (nanocrystal formulation), and ghrelin agonists are reviewed. The potential role of anabolic steroids is also discussed.

Publication types

  • Review

MeSH terms

  • Adipose Tissue / drug effects
  • Adipose Tissue / physiopathology
  • Aged
  • Aged, 80 and over
  • Aging*
  • Anabolic Agents / pharmacology
  • Anabolic Agents / therapeutic use*
  • Anorexia / drug therapy*
  • Anorexia / etiology
  • Anorexia / physiopathology
  • Appetite Stimulants / pharmacology
  • Appetite Stimulants / therapeutic use*
  • Feeding Behavior / drug effects
  • Frail Elderly*
  • Humans
  • Megestrol Acetate / therapeutic use
  • Muscular Atrophy / drug therapy*
  • Muscular Atrophy / etiology
  • Muscular Atrophy / physiopathology
  • Myostatin
  • Receptors, Androgen / drug effects
  • Receptors, Ghrelin / agonists
  • Transforming Growth Factor beta / antagonists & inhibitors
  • Weight Loss / drug effects*

Substances

  • Anabolic Agents
  • Appetite Stimulants
  • MSTN protein, human
  • Myostatin
  • Receptors, Androgen
  • Receptors, Ghrelin
  • Transforming Growth Factor beta
  • Megestrol Acetate